Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divis Laboratories Ltd reported Revenues for Q2FY25 of ₹2,338.00 Crores up from ₹1,909.00 Crore year on year, a rise of 22.47%.
Total Expenses for Q2FY25 of ₹1,722.00 Crores up from ₹1,526.00 Crores year on year, a rise of 12.84%.
Consolidated Net Profit of ₹510.00 Crores up 46.55% from ₹348.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹19.21, up 46.53% from ₹13.11 in the same quarter of the previous year.